| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |